UK markets open in 6 hours 36 minutes

Acacia Pharma Group plc (ACPGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.0700-0.0500 (-2.36%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.1200
Open2.0700
BidN/A x N/A
AskN/A x N/A
Day's range2.0700 - 2.0700
52-week range2.0700 - 3.4600
Volume2,000
Avg. volume0
Market cap175.895M
Beta (5Y monthly)2.02
PE ratio (TTM)N/A
EPS (TTM)-0.5300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption

    This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia Pharma Group plc Barhemsys® and Byfavo® launches continue to show strong progress gaining formulary access in 107 additional accounts over the past 3 monthsFor Barhemsys – 260 accounts on formulary with >80% win rate to date and well on track to meet annual formulary goal (300 accounts) by year endFor Byfavo – 95 accounts on formulary with >90% win rate to date, and

  • Globe Newswire

    Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets

    This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 29 September 2021: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or cancer chemotherapy, announce

  • Globe Newswire

    Correction: Notice of Results

    Correction for date of KOL webcast Acacia Pharma to Report its Interim Results for the Six Months ended 30 June 2021 on 30 September 2021 Conference Call to be held on 30 September at 14.00 CEST/08.00 EST Cambridge, UK and Indianapolis, US – 23 September 2021, 13:00 CEST: Acacia Pharma Group plc (“Acacia Pharma” or the "Company”) (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serio